撤回：唑尼沙胺对帕金森病和路易体痴呆的疗效与安全性：一项荟萃分析与系统评价
Retracted: Zonisamide's Efficacy and Safety on Parkinson's Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review.
作者信息
International BioMed Research
出版信息
Biomed Res Int. 2024 Jan 9;2024:9859863. doi: 10.1155/2024/9859863. eCollection 2024.
Abstract
[This retracts the article DOI: 10.1155/2022/4817488.].
摘要
[本文撤回文章DOI: 10.1155/2022/4817488。]
相似文献
1
Retracted: Zonisamide's Efficacy and Safety on Parkinson's Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review.撤回：唑尼沙胺对帕金森病和路易体痴呆的疗效与安全性：一项荟萃分析与系统评价
Biomed Res Int. 2024 Jan 9;2024:9859863. doi: 10.1155/2024/9859863. eCollection 2024.
2
Zonisamide's Efficacy and Safety on Parkinson's Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review.左乙拉西坦治疗帕金森病和路易体痴呆的疗效和安全性：Meta 分析和系统评价。
Biomed Res Int. 2022 Sep 12;2022:4817488. doi: 10.1155/2022/4817488. eCollection 2022.
4
Altered awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review.帕金森病和路易体痴呆认知和神经精神症状意识改变：系统评价。
Int J Geriatr Psychiatry. 2021 Jan;36(1):15-30. doi: 10.1002/gps.5415. Epub 2020 Sep 14.
5
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
6
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.胆碱酯酶抑制剂和盐酸美金刚在帕金森病认知障碍、帕金森病痴呆和路易体痴呆中的疗效和安全性：系统评价和荟萃分析及试验序贯分析。
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):135-43. doi: 10.1136/jnnp-2014-307659. Epub 2014 May 14.
7
Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.鉴别路易体痴呆与阿尔茨海默病及帕金森病痴呆：影像学方法的最新进展。
J Neurol. 2022 Feb;269(2):639-653. doi: 10.1007/s00415-021-10402-2. Epub 2021 Jan 29.
8
Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.123I-MIBG 心脏闪烁显像术诊断路易体相关性疾病的荟萃分析。
Mov Disord. 2011 Jun;26(7):1218-24. doi: 10.1002/mds.23659. Epub 2011 Apr 7.
9
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.LRP10 基因变异与家族性帕金森病和路易体痴呆：全基因组连锁和测序研究。
Lancet Neurol. 2018 Jul;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0. Epub 2018 Jun 7.
10
Dementia in Parkinson's disease: cause and treatment.帕金森病中的痴呆：病因与治疗
Curr Opin Neurol. 2004 Aug;17(4):399-404. doi: 10.1097/01.wco.0000137529.30750.ab.
本文引用的文献
1
Zonisamide's Efficacy and Safety on Parkinson's Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review.左乙拉西坦治疗帕金森病和路易体痴呆的疗效和安全性：Meta 分析和系统评价。
Biomed Res Int. 2022 Sep 12;2022:4817488. doi: 10.1155/2022/4817488. eCollection 2022.
Zotero 插件